ICPT’s PDUFA date for NASH extended beyond 3/26/20 due to FDA advisory panel on 4/22/20: http://ir.interceptpharma.com/news-releases/news-release-details/intercept-provides-regulatory-update This info was buried in a PR announcing ICPT’s submission of an MAA to the EMA for Ocaliva in NASH. I predict that Ocaliva is going to get massacred at the 4/22/20 advisory panel (#msg-152659994).